Use of Rimegepant in the Management of Cervicogenic Headache Secondary to Trauma: A Case Series

Use of Rimegepant in the Management of Cervicogenic Headache Secondary to Trauma: A Case Series

A cervicogenic headache (CH) originates from a cervical source. Multiple diagnostic criteria and treatment strategies for CH are present. Rimegepant is a calcitonin gene-related peptide receptor (CGRP) antagonist. We present a case series of three patients with CH who reported varying degrees of dec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2023-02, Vol.15 (2), p.e34662
Hauptverfasser: Zaw, Shin T, Zaw, Thinzar, Torres, Benito
Format: Artikel
Sprache:eng
Schlagworte:
Case reports
Chiropractic medicine
Consciousness
Fainting
Headaches
Nausea
Neck pain
Nonsteroidal anti-inflammatory drugs
Pain Management
Patients
Physical Medicine & Rehabilitation
Physical therapy
Trauma
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A cervicogenic headache (CH) originates from a cervical source. Multiple diagnostic criteria and treatment strategies for CH are present. Rimegepant is a calcitonin gene-related peptide receptor (CGRP) antagonist. We present a case series of three patients with CH who reported varying degrees of decreased headache intensity after using rimegepant.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.34662